Kerry manufactures a line of functional excipients that are co-processed and designed for direct tableting operations for use in orally dissolving tablets or for use in tablets where a hard tablet with fast dissolution is desired.

Disintequik? MCC25? is a co-processed excipient designed for use in orally dissolving tablets – i.e., designed to be dissolved on the tongue rather than swallowed whole.

Disintequik ODT is a co-processed excipient designed for direct tabletting operations for use in orally disintegrating tablets in that the tablet is designed to be dissolved on the tongue.